Affiliation:
1. Centre for Virus Research, Westmead Millennium Institute and University of Sydney, Westmead, New South Wales 2145, Australia
Abstract
ABSTRACT
During primary varicella-zoster virus (VZV) infection, it is presumed that virus is transmitted from mucosal sites to regional lymph nodes, where T cells become infected. The cell type responsible for VZV transport from the mucosa to the lymph nodes has not been defined. In this study, we assessed the susceptibility of human monocyte-derived dendritic cells to infection with VZV. Dendritic cells were inoculated with the VZV strain Schenke and assessed by flow cytometry for VZV and dendritic cell (CD1a) antigen expression. In five replicate experiments, 34.4% ± 6.6% (mean ± SEM) of CD1a
+
cells were also VZV antigen positive. Dendritic cells were also shown to be susceptible to VZV infection by the detection of immediate-early (IE62), early (ORF29), and late (gC) gene products in CD1a
+
dendritic cells. Infectious virus was recovered from infected dendritic cells, and cell-to-cell contact was required for transmission of virus to permissive fibroblasts. VZV-infected dendritic cells showed no significant decrease in cell viability or evidence of apoptosis and did not exhibit altered cell surface levels of major histocompatibility complex (MHC) class I, MHC class II, CD86, CD40, or CD1a. Significantly, when autologous T lymphocytes were incubated with VZV-infected dendritic cells, VZV antigens were readily detected in CD3
+
T lymphocytes and infectious virus was recovered from these cells. These data provide the first evidence that dendritic cells are permissive to VZV and that dendritic cell infection can lead to transmission of virus to T lymphocytes. These findings have implications for our understanding of how virus may be disseminated during primary VZV infection.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference39 articles.
1. Varicella zoster virus immune evasion;Abendroth A.;Immunol. Rev.,1999
2. Modulation of Major Histocompatibility Class II Protein Expression by Varicella-Zoster Virus
3. Arvin
A. M.
Varicella zoster virus
Fields virology.
Fields
B. N.
Knipe
D. M.
Howley
P. M.
1996
2547
2585
Raven
New York N.Y
4. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine;Arvin A. M.;Adv. Virus Res.,1996
5. Arvin
A. M.
Varicella zoster virus: virologic and immunologic aspects of persistent infection
Persistent viral infections.
Ahmed
R.
Chen
I.
1998
183
208
John Wiley and Sons Ltd.
New York N.Y
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献